LON:PRM - Proteome Sciences Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 3.60 0.00 (0.00 %) (As of 02/23/2020 03:32 PM ET) Add Compare Today's Range 3.21Now: GBX 3.60▼ 3.6550-Day Range 2.94MA: GBX 3.35▼ 3.7552-Week Range 2.20Now: GBX 3.60▼ 4.30Volume20,927 shsAverage Volume88,695 shsMarket Capitalization£10.63 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, isobaric reagents, and biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:PRM Previous Symbol CUSIPN/A CIKN/A Webhttp://www.proteomics.com/ Phone+44-20-70432116Debt Debt-to-Equity RatioN/A Current Ratio0.31 Quick Ratio0.22Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£3.47 million Price / Sales3.07 Cash FlowGBX 0.30 per share Price / Cash Flow12.00 Book ValueGBX (1.40) per share Price / Book-2.57Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees29 Outstanding Shares295,182,016Market Cap£10.63 million Next Earnings DateN/A OptionableNot Optionable Receive PRM News and Ratings via Email Sign-up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter. LSE:PRM Rates by TradingView Proteome Sciences (LON:PRM) Frequently Asked Questions What is Proteome Sciences' stock symbol? Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM." Has Proteome Sciences been receiving favorable news coverage? Media headlines about PRM stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Proteome Sciences earned a news impact score of -2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Proteome Sciences. Who are some of Proteome Sciences' key competitors? Some companies that are related to Proteome Sciences include VolitionRX (VNRX), Spectral Medical (EDT), ANGLE (AGL), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT). What other stocks do shareholders of Proteome Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), Boohoo Group (BOO), Mondi (MNDI), Petrofac (PFC), Falanx Group (FLX), Lloyds Banking Group (LLOY), Quanterix (QTRX), Centrica (CNA), Cyanconnode (CYAN) and Eckoh (ECK). Who are Proteome Sciences' key executives? Proteome Sciences' management team includes the folowing people: Dr. Jeremy Rupert Michael Haigh, CEO & Exec. Director (Age 58)Dr. Ian H. Pike, Chief Scientific Officer & Exec. DirectorMr. Richard Paul Dennis, Chief Commercial Officer & Exec. Director (Age 60)Mr. Stefan Fuhrmann, Interim Fin. DirectorDr. Josef Schwarz, Chief Compliance Officer How do I buy shares of Proteome Sciences? Shares of PRM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Proteome Sciences' stock price today? One share of PRM stock can currently be purchased for approximately GBX 3.60. How big of a company is Proteome Sciences? Proteome Sciences has a market capitalization of £10.63 million and generates £3.47 million in revenue each year. Proteome Sciences employs 29 workers across the globe.View Additional Information About Proteome Sciences. What is Proteome Sciences' official website? The official website for Proteome Sciences is http://www.proteomics.com/. How can I contact Proteome Sciences? Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The company can be reached via phone at +44-20-70432116. MarketBeat Community Rating for Proteome Sciences (LON PRM)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 158 (Vote Outperform)Underperform Votes: 238 (Vote Underperform)Total Votes: 396MarketBeat's community ratings are surveys of what our community members think about Proteome Sciences and other stocks. Vote "Outperform" if you believe PRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: How does a security become overbought?
